• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Lipids and hypertension. Implications of new guidelines for cholesterol management in the treatment of hypertension.

作者信息

Grimm R H, Hunninghake D B

出版信息

Am J Med. 1986 Feb 14;80(2A):56-63. doi: 10.1016/0002-9343(86)90161-0.

DOI:10.1016/0002-9343(86)90161-0
PMID:3946462
Abstract

The approach to management of cardiovascular risk factors has been greatly enhanced by the recent publication of results from several large intervention studies. This increased knowledge has led to rapid changes in perspective and to some controversies regarding cardiovascular risk management. The major cardiovascular disease risk factors are high blood pressure, elevated serum cholesterol, and cigarette smoking. In the past, physicians have paid little attention to the latter two factors, focusing primarily on severe hypertension. Initially, the pharmacologic treatment of hypertension consisted mostly of thiazide diuretics, since they were the only agents generally available that were well-tolerated by most patients. Over the past decade, however, new data from large-scale intervention studies and the development of many new classes of antihypertensive agents have considerably improved the approach to managing all three primary risk factors. Recently published results of major clinical trials are likely to further alter physicians' perspectives and influence their practice habits. This article proposes an approach to comprehensive risk management that simultaneously involves all the major risk factors, with emphasis on blood pressure and lipids. The rationale for this integrated approach is based on the following facts: Hypertension trials have not convincingly demonstrated that lowering blood pressure alone reduces the risk for coronary heart disease; Cholesterol lowering has been shown conclusively to reduce the risk of coronary heart disease; Several classes of antihypertensive agents have now been found to significantly affect blood lipids, either adversely or beneficially; and Past observational epidemiologic studies have shown a positive association between blood lipids (cholesterol and triglycerides) and blood pressure, implying that these two conditions commonly occur together. The background supporting these facts, as well as a practical approach to the treatment of hypertension that takes into consideration the management of blood lipids, is provided in this article.

摘要

相似文献

1
Lipids and hypertension. Implications of new guidelines for cholesterol management in the treatment of hypertension.
Am J Med. 1986 Feb 14;80(2A):56-63. doi: 10.1016/0002-9343(86)90161-0.
2
Antihypertensive therapy and lipids. Evidence, mechanisms, and implications.
Arch Intern Med. 1985 Jun;145(6):1102-5.
3
Effects of prazosin on serum lipids in patients with essential hypertension: a review of the findings presented at the Satellite Symposium on coronary heart disease: hypertension and other risk factors, Milan, 1983.哌唑嗪对原发性高血压患者血脂的影响:1983年在米兰举行的冠心病卫星专题研讨会(高血压及其他危险因素)上所展示研究结果的综述
Am J Cardiol. 1984 Jan 27;53(3):21A-23A. doi: 10.1016/0002-9149(84)90830-0.
4
Management of hypertension. Potential trade-offs on coronary risk.高血压的管理。冠状动脉风险方面的潜在权衡。
Am J Med. 1989 Aug 16;87(2A):62S-65S. doi: 10.1016/0002-9343(89)90116-2.
5
Antihypertensive therapy: taking lipids into consideration.抗高血压治疗:考虑血脂因素。
Am Heart J. 1991 Sep;122(3 Pt 2):910-8. doi: 10.1016/0002-8703(91)90811-u.
6
Antihypertensive therapy and lipids. Paradoxical influences on cardiovascular disease risk.抗高血压治疗与血脂。对心血管疾病风险的矛盾影响。
Am J Med. 1986 Feb 14;80(2A):64-70. doi: 10.1016/0002-9343(86)90162-2.
7
Studies on the effect of prazosin on blood pressure and serum lipids in Japanese hypertensive patients.关于哌唑嗪对日本高血压患者血压和血脂影响的研究。
Am J Med. 1984 Feb 27;76(2A):117-21. doi: 10.1016/0002-9343(84)90969-0.
8
Lipids, lipoproteins, and coronary heart disease: implications for antihypertensive therapy.脂质、脂蛋白与冠心病:对降压治疗的启示
Cardiovasc Drugs Ther. 1989 Jun;3 Suppl 1:333-40. doi: 10.1007/BF00148479.
9
Effects of prazosin and propranolol on blood lipids and lipoproteins in hypertensive patients.哌唑嗪和普萘洛尔对高血压患者血脂及脂蛋白的影响。
Am J Med. 1986 Feb 14;80(2A):109-13. doi: 10.1016/0002-9343(86)90169-5.
10
Effects of oral antihypertensive agents on blood lipid levels.口服抗高血压药物对血脂水平的影响。
Clin Ther. 1986;8(3):309-19.

引用本文的文献

1
Nutrition education practices and opinions of alberta family physicians.阿尔伯塔省家庭医生的营养教育实践和观点。
Can Fam Physician. 1990 Jan;36:53-8.
2
After-hours Care: Where is your Family Doctor?非工作时间护理:你的家庭医生在哪里?
Can Fam Physician. 1990 Feb;36:201-6.
3
A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.卡维地洛与卡托普利对轻度至中度原发性高血压合并血脂异常患者血脂浓度影响的双盲比较。
Eur J Clin Pharmacol. 1993;45(2):95-100. doi: 10.1007/BF00315487.
4
Pharmacotherapy for benign prostatic hyperplasia.良性前列腺增生的药物治疗
West J Med. 1994 Nov;161(5):495-506.
5
Antihypertensive therapy, serum lipids, coronary heart disease and hypertension--balancing the risks and benefits of treatment.抗高血压治疗、血脂、冠心病与高血压——权衡治疗的风险与获益
West J Med. 1986 Aug;145(2):219-21.
6
On a wing and a prayer: health care in the Peruvian jungle.仅靠微薄的希望:秘鲁丛林中的医疗保健。
CMAJ. 1987 Nov 15;137(10):949-53.
7
Borderline hypercholesterolaemia: when to introduce drugs.边缘性高胆固醇血症:何时开始用药。
Postgrad Med J. 1989 Aug;65(766):543-52. doi: 10.1136/pgmj.65.766.543.